Randomized Phase III Trial Comparing Weekly Docetaxel Plus Cisplatin Versus Docetaxel Monotherapy Every 3 Weeks in Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Intergroup Trial JCOG0803/WJOG4307L
Abe T, Takeda K, Ohe Y, Kudoh S, Ichinose Y, Okamoto H, Yamamoto N, Yoshioka H, Minato K, Sawa T, Iwamoto Y, Saka H, Mizusawa [...]
Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer.
Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K. J Clin Oncol. 2015 Mar 1;33(7):716-22. doi: 10.1200/JCO.2014.57.2743. Epub 2015 Jan [...]
Can older women with early breast cancer avoid radiation?
Hughes KS, Schnaper LA. Lancet Oncol. 2015 Mar;16(3):235-7. doi: 10.1016/S1470-2045(15)70014-8. Epub 2015 Jan 28. (The Lancet Oncology)
Expert consensus panel guidelines on geriatric assessment in oncology
O'Donovan A, Mohile SG, Leech M. Eur J Cancer Care (Engl). 2015 Jul;24(4):574-89. doi: 10.1111/ecc.12302. Epub 2015 Mar 11. (Pubmed)
Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)
Lamont EB, Schilsky RL, He Y, Muss H, Cohen HJ, Hurria A, Meilleur A, Kindler HL, Venook A, Lilenbaum R, Niell H, Goldberg RM, Joffe [...]
Minimize toxicity or preserve efficacy? A delicate trade-off in the management of older patients with lung cancer
Owonikoko TK, Ramalingam SS. J Clin Oncol. 2015 Feb 20;33(6):534-6. doi: 10.1200/JCO.2014.59.5033. Epub 2015 Jan 12. (Journal of Clinical Oncology)
Tumor marker usage and medical care costs among older early-stage breast cancer survivors
Ramsey SD, Henry NL, Gralow JR, Mirick DK, Barlow W, Etzioni R, Mummy D, Thariani R, Veenstra DL. J Clin Oncol. 2015 Jan 10;33(2):149-55. doi: [...]
Polypharmacy: Geriatric Oncology Evaluation Should Become Mainstream
Lichtman SM. J Clin Oncol. 2015 Mar 23. pii: JCO.2014.60.3548. [Epub ahead of print] (Journal of Clinical Oncology)
Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?
Shumway DA, Hamstra DA. J Clin Oncol. 2015 Mar 1;33(7):676-8. doi: 10.1200/JCO.2014.59.4093. Epub 2015 Jan 5. (Journal of Clinical Oncology)
Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report.
Ostronoff F, Othus M, Lazenby M, Estey E, Appelbaum FR, Evans A, Godwin J, Gilkes A, Kopecky KJ, Burnett A, List AF, Fang M, Oehler [...]
A review of the management of elderly patients with non-small-cell lung cancer.
Blanco R, Maestu I, de la Torre MG, Cassinello A, Nuñez I. Ann Oncol. 2015 Mar;26(3):451-63. doi: 10.1093/annonc/mdu268. Epub 2014 Jul 24. (Annals of Oncology)
Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.
Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. J Clin Oncol. 2015 May 1;33(13):1453-9. doi: 10.1200/JCO.2014.58.7550. Epub 2015 Mar 23. (Pubmed)